Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-79.53	1798.58	-8785.18
Graham Fair Price	-4.57	0.92	0.96
PEG	544.73	1.40	0.22
Price/Book	-3.11	0.19	0.20
Price/Cash Flow	-62.76	39.44	-105.92
Prices/Earnings	-18.03	-18.25	-15.46
Price/Sales	3.52	3.86	3.73
Price/FCF	-62.76	39.44	-105.92
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	17.91	0.24	0.21
Operating Margin	16.70	-0.05	-0.06
ROA	18.17	< 0.005	< 0.005
ROE	< 0.005	< 0.005	17.91
ROIC	< 0.005	< 0.005	24.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	< 0.005	-168.82
Dividends QOQ	-0.73	0.99	36.36
EBIT QOQ	0.68	0.22	-67.32
EPS QOQ	0.71	0.13	-81.69
FCF QOQ	-1.57	3.59	128.83
Revenue QOQ	0.05	-0.07	38.00
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	135.41	157.23	16.11
Days Sales Outstanding (DSO)	1523.58	1689.46	10.89
Inventory Turnover	0.66	0.57	-13.88
Debt/Capitalization	0.48	0.48	-0.26
Quick Ratio	0.82	0.83	1.22
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	3.58	3.77	5.33
Cash	1.23	1.25	1.91
Capex	< 0.005	-0.01	-590.71
Free Cash Flow	< 0.005	0.02	174.06
Revenue	0.19	0.19	-1.42
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.91	0.92	0.93
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-6391.09	1324.95	-79.27
Naive Interpretation	Member

06 - Financial Health · Bad

Rating